Literature DB >> 15338685

Sodium and volume overload in peritoneal dialysis: limitations of current treatment and possible solutions.

Mukesh Khandelwal1, Dimitrios Oreopoulos.   

Abstract

Cardiovascular disease is a leading cause of death in patients with chronic kidney disease. Recent evidence suggests that hypertension and subclinical volume expansion is common in patients on peritoneal dialysis. Moreover, recent studies pointed out that sodium removal is limited in patients on peritoneal dialysis and mortality has been shown to co-relate with fluid and sodium removal. Treatment of sodium and fluid removal includes dietary salt and fluid restriction, use of diuretics, icodextrin, strategies also considered helpful to control hypertension. Despite availability of these measures, prevalence of hypertension remains high in PD patients. Hence, innovative strategies are urgently required to address this common and difficult clinical problem. This article reviews limitations of available measures to manage sodium and fluid overload and hypertension and suggests possible role and place of low sodium dialysis solutions in PD patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338685     DOI: 10.1023/b:urol.0000032699.91947.7f

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.

Authors:  J F Medcalf; K P Harris; J Walls
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

2.  Controlled sodium removal with peritoneal dialysis.

Authors:  D J Ahearn; K D Nolph
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

3.  Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function.

Authors:  M K Menon; D M Naimark; J M Bargman; S I Vas; D G Oreopoulos
Journal:  Nephrol Dial Transplant       Date:  2001-11       Impact factor: 5.992

4.  Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.

Authors:  G Woodrow; G Stables; B Oldroyd; J Gibson; J H Turney; A M Brownjohn
Journal:  Nephrol Dial Transplant       Date:  1999-06       Impact factor: 5.992

5.  Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study.

Authors:  R Cocchi; E Degli Esposti; A Fabbri; A Lucatello; A Sturani; F Quarello; R Boero; M Bruno; C Dadone; A Favazza; R Scanziani; A Tommasi; A Giangrande
Journal:  Nephrol Dial Transplant       Date:  1999-06       Impact factor: 5.992

6.  Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.

Authors:  O Ortega; P Gallar; A Carreño; M Gutierrez; I Rodriguez; A Oliet; A Vigil; E Gimenez
Journal:  Am J Nephrol       Date:  2001 May-Jun       Impact factor: 3.754

7.  Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.

Authors:  Joerg Plum; Stella Gentile; Christian Verger; Reinhart Brunkhorst; Udo Bahner; Bernadette Faller; Jacky Peeters; Philippe Freida; Dick G Struijk; Raymond T Krediet; Bernd Grabensee; Anders Tranaeus; José C Divino Filho
Journal:  Am J Kidney Dis       Date:  2002-04       Impact factor: 8.860

8.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

9.  Advantages of HCO3 solution with low sodium concentration over standard lactate solutions for acute peritoneal dialysis.

Authors:  J Vande Walle; A Raes; D Castillo; N Lutz-Dettinger; A Dejaegher
Journal:  Adv Perit Dial       Date:  1997

10.  Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.

Authors:  Ana Rodríguez-Carmona; Miguel Pérez Fontán
Journal:  Perit Dial Int       Date:  2002 Nov-Dec       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.